市場調査レポート
商品コード
1369133

医療診断向けAIの世界市場 (~2028年):モダリティ ・用途・ユーザー別の分析・予測・アンメットニーズ・主要ステークホルダー・購入基準

Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound), Application (IVD, Radiology, CNS, CVS, Ob/Gyn), User (Hospital, Labs), Unmet Need, Key Stakeholders & Buying Criteria - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 327 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
医療診断向けAIの世界市場 (~2028年):モダリティ ・用途・ユーザー別の分析・予測・アンメットニーズ・主要ステークホルダー・購入基準
出版日: 2023年10月19日
発行: MarketsandMarkets
ページ情報: 英文 327 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医療診断向けAIの市場規模は、2023年の13億米ドルから、予測期間中は23.2%のCAGRで推移し、2028年には37億米ドルの規模に成長すると予測されています。

医療診断におけるAIの採用は、AI技術の取り込みを促進するための政府によるさまざまなイニシアチブの増加、作業負荷を軽減するための放射線科医によるAIソリューションの利用の拡大、業界を超えた提携・協力の増加などの要因により、速いペースで上昇しています。

調査範囲
調査対象年 2017-2028年
基準年 2022年
予測期間 2023-2028年
単位 金額 (米ドル)
セグメント コンポーネント・用途・エンドユーザー・地域
対象地域 北米・欧州・アジア太平洋・ラテンアメリカ・中東&アフリカ

コンポーネント別で見ると、ソフトウェアの部門が2022年に最大のシェアを示し、予測期間中はサービス部門がに最大の成長率を示すと予測されています。ソフトウェアソリューションは、人手不足や画像スキャン件数の増加といった課題にもかかわらず、ヘルスケアプロバイダーに競争上の優位性をもたらしています。

用途別では、生体内診断の部門が2023年に最大のシェアを示しています。開業医によるAIソリューションの導入が進んでいること、これらのソリューションが常にヒューマンエラーの減少に役立ち、治療効果を高めることなどといった要因が同部門の成長を推進しています。一方、予測期間中は、体外診断の部門が最大の成長を示す見通しです。

地域別では、北米地域が2023年に最大のシェアを示しました。一方、予測期間中は、アジア太平洋地域が最大のCAGRを記録すると予測されています。癌の有病率の増加や、有利な政府イニシアチブの実施などの要因が同地域の成長を推進する見通しです。

当レポートでは、世界の医療診断向けAIの市場を調査し、市場概要、市場影響因子および市場機会の分析、技術・特許動向、ケーススタディ、法規制・償還環境、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 顧客の事業に影響を与える動向/ディスラプション
  • バリューチェーン分析
  • エコシステムマッピング
  • ケーススタディ
  • 技術分析
  • ポーターのファイブフォース分析
  • 産業動向
  • 貿易分析
  • 関税と規制の分析
  • 価格分析
  • 特許分析
  • 主要な会議とイベント
  • 主要なステークホルダーと購入基準
  • アンメットニーズ
  • エンドユーザーの期待
  • 償還シナリオ

第6章 医療診断向けAI市場:コンポーネント別

  • ソフトウェア
  • サービス
  • ハードウェア
    • プロセッサー
    • メモリ
    • ネットワーク

第7章 医療診断向けAI市場:用途別

  • 生体内診断
    • 専門分野別
    • モダリティ別
  • 体外診断

第8章 医療診断向けAI市場:エンドユーザー別

  • 病院
  • 画像診断センター
  • 診断ラボ
  • その他

第9章 医療診断向けAI市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 収益分析
  • 市場シェア分析
  • 企業評価マトリックス
  • 新興企業/中小企業の評価マトリックス
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • MICROSOFT
    • NVIDIA CORPORATION
    • MERATIVE
    • GOOGLE(ALPHABET, INC.)
    • INTEL CORPORATION
    • SIEMENS HEALTHINEERS
    • GE HEALTHCARE
    • ADVANCED MICRO DEVICES, INC.
    • KONINKLIJKE PHILIPS N.V.
    • DIGITAL DIAGNOSTICS, INC.
    • INFORMAI
  • その他の企業
    • HEARTFLOW, INC.
    • ENLITIC, INC.
    • AIDENCE
    • BUTTERFLY NETWORK, INC.
    • NANO X IMAGING LTD.
    • VIZ.AI, INC.
    • QUIBIM
    • QURE.AI
    • THERAPIXEL
    • AIDOC
    • LUNIT, INC.
    • ECHONOUS, INC.
    • ICOMETRIX
    • BRAINOMIX

第12章 付録

目次
Product Code: HIT 7875

The global AI in medical diagnostics market is projected to reach USD 3.7 Billion by 2028 from USD 1.3 Billion in 2023, at a CAGR of 23.2% during the forecast period. The adoption of AI in medical diagnostics is rising at a fast pace owing to factors such as growth in various government initiatives to drive the uptake of AI-based technologies, AI solutions being more use by radiologists to decrease workload and the increasing number of cross-industry partnerships & collaborations.

Scope of the Report
Years Considered for the Study2017-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsComponent, Application, End User, And Region
Regions coveredNorth America, Europe , Asia Pacific, Latin America, Middle East & Africa.

However, the shortage of trained AI workforce, and unstable regulations are factors expected to restrain the market growth.

"Services segment is expected to grow at the highest rate from 2023 to 2028"

By component, AI in medical diagnostics market is divided into software,hardware, and services. The software segment accounted for the largest share of this market in 2022, while the services segment is estimated to grow at a higher CAGR from 2023 to 2028. Software solutions provide healthcare providers to gain a competitive edge despite the challenges of being short-staffed and facing mounting imaging scan volumes.

"In Vivo Diagnostics Segment is estimated to account for the largest share of the global AI in medical diagnostics market in 2023"

By application, AI in medical diagnostics market is divided into in vivo and in vitro diagnostics. In 2023, the in vivo diagnostics segment is projected to hold the largest share this market. Factors such as growing uptake of AI solutions by practitioners, as these solutions constantly help in decreasing human errors and enhance treatment efficacy.However,the in vitro diagnostics segment is projected to register highest growth during forecast period. The adoption of AI solutions is increasing for in vitro diagnostics applications as these solutions help reduce analysis and data interpretation time.

"The Hospitals segment is estimated to account for the largest share of the global AI in medical diagnostics market in 2023"

By end users, the AI in medical diagnostics market is divided into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. In 2023, the hospitals segment is projected to hold the largest market share of this market. Factors such as the increase in the adoption of minimally invasive procedures in hospitals to enhance the quality of patient care, and the advance in the application of advanced imaging modalities to improve workflow.

"North America to dominate the AI in medical diagnostics market in 2023."

By region, AI in medical diagnostics market has been segmented into five main regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America estimated to account for the largest market share of this market. However, the Asia Pacific market is projected to register the highest CAGR from 2023 to 2028. Factors such as increasing prevalence of cancer, and the implementation of favorable government initiatives.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level (27%), Director-level (18%), and Others (55%)
  • By Region: North America (40%), Europe (20%), Asia Pacific (30%), and RoW (10%)

The prominent players in this market are Microsoft (US), NVIDIA Corporation (US), Merative (US), Intel Corporation (US), Google (US), Siemens Healthineers (Germany), GE HealthCare (US), Digital Diagnostics Inc. (US), Advanced Micro Devices, Inc. (US), InformAI (US), HeartFlow, Inc. (US), Enlitic, Inc. (US), isometric (Belgium), Aidence (Netherlands), Butterfly Network, Inc. (US), Nano-X Imaging LTD. (Israel), Viz.ai, Inc (US), Quibim (Spain), Qure.ai (India), Therapixel (France), Aidoc (US), Koninklijke Philips N.V. (Netherlands), Lunit, Inc. (South Korea), EchoNous, Inc. (US), and Brainomix (UK).

Research Coverage

  • The report studies the AI in medical diagnostics market based on component, application, end user, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in medical diagnostics market
  • The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the AI in medical diagnostics market and provides them information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (influx of big data, growing cross-industry partnerships & collaborations, Increasing adoption of AI solutions to reduce work pressure on radiologists, rising government initiatives to drive AI-based technologies, availability of funding for AI-based startups), restraints (inadequate AI workforce and ambiguous regulatory guidelines for medical software), opportunities (untapped emerging markets, increasing focus on developing human-aware AI systems, challenges (reluctance to adopt AI-based technologies,budgetary constraints, unstructured healthcare data,data privacy concerns,limited interoperability)
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global AI in medical diagnostics Market. The report analyzes this market by component, application, end user.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends in the global AI in medical diagnostics Market
  • Market Development: Comprehensive information on the lucrative emerging markets by component, application, end user.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global AI in medical diagnostics Market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global AI in medical diagnostics Market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 5 MARKET SIZE ESTIMATION
    • TABLE 1 FACTOR ANALYSIS
    • FIGURE 6 AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS
  • 2.5 LIMITATIONS
    • 2.5.1 SCOPE-RELATED LIMITATIONS
    • 2.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET
  • 2.7 AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
    • FIGURE 14 RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF BIG DATA TO DRIVE MARKET
  • 4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2022)
    • FIGURE 15 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA IN 2022
  • 4.3 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE
  • 4.4 AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX
    • FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 AI IN MEDICAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
    • FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 DRIVERS
      • 5.1.1.1 Influx of big data
      • 5.1.1.2 Growing cross-industry partnerships & collaborations
      • 5.1.1.3 Increasing demand for AI-based solutions to reduce work pressure on radiologists
      • 5.1.1.4 Rising government initiatives to support AI-based technologies
      • 5.1.1.5 Availability of funding for AI-based startups
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 Inadequate AI workforce and ambiguous regulatory guidelines for medical software
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Untapped emerging markets
      • 5.1.3.2 Increasing focus on developing human-aware AI systems
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Reluctance to adopt AI-based technologies
      • 5.1.4.2 Budgetary constraints
      • 5.1.4.3 Unstructured healthcare data
      • 5.1.4.4 Data privacy concerns
      • 5.1.4.5 Limited interoperability
  • 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
    • FIGURE 20 REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 21 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN
    • 5.3.1 UPSTREAM
    • 5.3.2 MID-STREAM
    • 5.3.3 DOWNSTREAM
  • 5.4 ECOSYSTEM MAPPING
    • FIGURE 22 AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM
    • 5.4.1 ROLE IN ECOSYSTEM
  • 5.5 CASE STUDIES
    • 5.5.1 MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM
    • 5.5.2 RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES
    • 5.5.3 NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING
    • 5.5.4 ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND
    • 5.5.5 WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 MACHINE LEARNING
    • 5.6.2 NATURAL LANGUAGE PROCESSING
    • 5.6.3 COMPUTER VISION
    • TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 INDUSTRY TRENDS
    • 5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE
      • 5.8.1.1 Key to AI in Healthcare: Data
      • 5.8.1.2 AR and MR in Healthcare Settings
      • 5.8.1.3 Healthcare Privacy and Security in 2022
      • 5.8.1.4 Growing demand for AI among companies offering at-home IVD testing services
  • 5.9 TRADE ANALYSIS
    • FIGURE 23 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
    • FIGURE 24 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND)
  • 5.10 TARIFF AND REGULATORY ANALYSIS
    • 5.10.1 TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE
    • TABLE 5 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022
    • TABLE 6 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022
    • TABLE 7 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.3 NORTH AMERICA
    • FIGURE 25 ALGORITHMS CLEARED BY US FDA, 2008 TO 2023
      • 5.10.3.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
      • 5.10.3.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH)
      • 5.10.3.3 Consumer Privacy Protection Act of 2017
      • 5.10.3.4 National Cybersecurity Protection Advancement Act of 2015
      • 5.10.3.5 Future of Life Institute's Asilomar AI Principles
    • 5.10.4 EUROPE
      • 5.10.4.1 European Medical Devices Regulation (EU) 2017/745 and In-vitro Diagnostic Medical Devices Regulation (EU) 2017/746, in combination with General Data Protection Regulation 2016/679
      • 5.10.4.2 AI Act (Artificial Intelligence Act)
    • 5.10.5 ASIA PACIFIC
      • 5.10.5.1 Cybersecurity Law of the People's Republic of China
    • 5.10.6 REST OF THE WORLD
      • 5.10.6.1 Protection of Personal Information Act
  • 5.11 PRICING ANALYSIS
    • FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR)
    • TABLE 12 AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE
    • 5.11.1 AVERAGE SELLING PRICE TREND
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS
    • FIGURE 27 PATENT PUBLICATION TRENDS (2019-2023)
    • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023)
    • TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET
  • 5.13 KEY CONFERENCES AND EVENTS (2023-2024)
    • TABLE 14 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
    • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
    • 5.14.2 BUYING CRITERIA
    • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
    • TABLE 17 KEY BUYING CRITERIA FOR END USERS
  • 5.15 UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET
    • TABLE 18 AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS
  • 5.16 END-USER EXPECTATIONS
    • TABLE 19 AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS
  • 5.17 REIMBURSEMENT SCENARIO
    • TABLE 20 SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE
    • TABLE 21 DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT
    • 5.17.1 REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY

6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
  • 6.2 SOFTWARE
    • 6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS
    • TABLE 24 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 25 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH
    • TABLE 26 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 27 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
  • 6.4 HARDWARE
    • 6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
    • TABLE 28 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 29 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 30 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 31 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • 6.4.2 PROCESSORS
    • TABLE 32 PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 33 PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 34 PROCESSORS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 35 PROCESSORS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.2.1 MPU
        • 6.4.2.1.1 MPUs to hold largest share of processors market
    • TABLE 36 MPU MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 37 MPU MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.2.2 GPU
        • 6.4.2.2.1 GPUs play crucial role in enhancing accuracy and efficacy of imaging
    • TABLE 38 GPU MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 39 GPU MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.2.3 FPGA
        • 6.4.2.3.1 Wide usage potential to drive demand
    • TABLE 40 FPGA MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 41 FPGA MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.2.4 ASIC
        • 6.4.2.4.1 Rapid operations to support end-user demand
    • TABLE 42 ASIC MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 43 ASIC MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • 6.4.3 MEMORY
      • 6.4.3.1 Development of high-bandwidth memory for AI applications to drive market
    • TABLE 44 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 45 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • 6.4.4 NETWORKS
    • TABLE 46 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 47 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 48 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 49 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.4.1 Adapters
        • 6.4.4.1.1 Adapters to hold largest share of networks market
    • TABLE 50 ADAPTERS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 51 ADAPTERS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.4.2 Switches
    • TABLE 52 SWITCHES MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 53 SWITCHES MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
      • 6.4.4.3 Interconnects
        • 6.4.4.3.1 Need for efficient data transmission to drive market
    • TABLE 54 INTERCONNECTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 55 INTERCONNECTS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)

7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 56 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 57 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
  • 7.2 IN VIVO DIAGNOSTICS
    • 7.2.1 IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY
    • TABLE 58 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 59 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 60 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 61 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.1 Radiology
        • 7.2.1.1.1 AI-based diagnostic tools to reduce work pressure on radiologists
    • TABLE 62 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 63 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.2 Cardiology
        • 7.2.1.2.1 Rising complexities associated with CVD to drive market
    • TABLE 64 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 65 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.3 Neurology
        • 7.2.1.3.1 Increasing prevalence of critical brain disorders to drive market
    • TABLE 66 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 67 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.4 Obstetrics/Gynecology
        • 7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market
    • TABLE 68 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 69 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.5 Ophthalmology
        • 7.2.1.5.1 Rising need for early detection & prevention of eye diseases to drive market
    • TABLE 70 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 71 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.1.6 Other specialties
    • TABLE 72 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 73 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2022-2028 (USD MILLION)
    • 7.2.2 IN VIVO DIAGNOSTICS MARKET, BY MODALITY
    • TABLE 74 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 75 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 76 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 77 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.2.1 CT
        • 7.2.2.1.1 Rising availability of cardiac CT devices with AI solutions to drive market
    • TABLE 78 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 79 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.2.2 X-ray
        • 7.2.2.2.1 Innovative AI solutions for x-ray imaging by key players to drive market
    • TABLE 80 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 81 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.2.3 MRI
        • 7.2.2.3.1 Rising technological advancements to drive adoption of AI in MRI
    • TABLE 82 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 83 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.2.4 Ultrasound
        • 7.2.2.4.1 Increasing prevalence of ovarian cancer to boost demand
    • TABLE 84 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 85 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2022-2028 (USD MILLION)
      • 7.2.2.5 Other modalities
    • TABLE 86 FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING
    • TABLE 87 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 88 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2022-2028 (USD MILLION)
  • 7.3 IN VITRO DIAGNOSTICS
    • 7.3.1 INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
    • TABLE 89 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 90 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2028 (USD MILLION)

8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 91 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 92 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET
    • TABLE 93 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 94 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC IMAGING CENTERS
    • 8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
    • TABLE 95 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 96 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2022-2028 (USD MILLION)
  • 8.4 DIAGNOSTIC LABORATORIES
    • 8.4.1 RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET
    • TABLE 97 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 98 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2028 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 99 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 100 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2028 (USD MILLION)

9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 101 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017-2021 (USD MILLION)
    • TABLE 102 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 103 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 104 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 106 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 108 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 109 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 110 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 111 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 112 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 114 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 116 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 117 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 118 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 119 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 120 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Increasing volume of imaging procedures to drive market
    • TABLE 121 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 122 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 123 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 124 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 125 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 126 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 127 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 128 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 129 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 130 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 131 US: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 132 US: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 133 US: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 134 US: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 135 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 136 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Research grants and improved academics in radiology to drive market
    • TABLE 137 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 138 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 139 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 140 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 141 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 142 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 143 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 144 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 145 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 146 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 147 CANADA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 148 CANADA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 149 CANADA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 150 CANADA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 151 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 152 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 153 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 154 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 155 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 156 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 157 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 158 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 159 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 160 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 161 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 162 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 163 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 164 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 165 EUROPE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 166 EUROPE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 167 EUROPE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 168 EUROPE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 169 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 170 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Rising government support to drive adoption of AI in medical diagnostics
    • TABLE 171 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 172 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 173 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 174 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 175 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 176 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 177 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 178 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 179 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 180 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 181 GERMANY: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 182 GERMANY: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 183 GERMANY: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 184 GERMANY: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 185 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 186 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging
    • TABLE 187 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 188 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 189 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 190 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 191 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 192 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 193 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 194 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 195 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 196 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 197 FRANCE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 198 FRANCE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 199 FRANCE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 200 FRANCE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 201 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 202 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Increasing radiography procedures to drive market
    • TABLE 203 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 204 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 205 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 206 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 207 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 208 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 209 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 210 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 211 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 212 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 213 UK: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 214 UK: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 215 UK: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 216 UK: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 217 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 218 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Increasing volume of EHRs and EMRs due to rising geriatric population to drive demand for AI solutions
    • TABLE 219 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 220 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 221 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 222 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 223 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 224 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 225 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 226 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 227 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 228 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 229 ITALY: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 230 ITALY: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 231 ITALY: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 232 ITALY: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 233 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 234 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing awareness of AI in Spain to favor market growth
    • TABLE 235 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 236 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 237 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 238 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 239 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 240 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 241 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 242 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 243 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 244 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 245 SPAIN: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 246 SPAIN: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 247 SPAIN: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 248 SPAIN: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 249 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 250 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 251 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 252 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 253 REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 254 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 255 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 256 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 257 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 258 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 259 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 260 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 261 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 262 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 263 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 264 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 265 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 266 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 32 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 267 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 268 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 269 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 270 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 271 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 272 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 273 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 274 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 275 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 276 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 277 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 278 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 279 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 280 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 281 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 282 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 283 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 284 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Rising use of AI in clinical decision-making to drive market
    • TABLE 285 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 286 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 287 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 288 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 289 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 290 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 291 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 292 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 293 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 294 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 295 CHINA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 296 CHINA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 297 CHINA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 298 CHINA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 299 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 300 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI solutions
    • TABLE 301 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 302 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 303 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 304 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 305 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 306 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 307 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 308 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 309 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 310 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 311 JAPAN: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 312 JAPAN: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 313 JAPAN: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 314 JAPAN: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 315 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 316 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Favorable government initiatives for R&D investments to drive market
    • TABLE 317 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 318 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 319 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 320 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 321 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 322 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 323 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 324 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 325 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 326 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 327 INDIA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 328 INDIA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 329 INDIA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 330 INDIA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 331 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 332 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 333 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 334 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 335 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 336 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 337 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 338 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 339 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 340 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 341 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 342 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 343 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 344 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 345 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 346 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 347 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 348 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS
    • 9.5.2 LATIN AMERICA: RECESSION IMPACT
    • TABLE 349 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 350 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 351 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 352 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 353 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 354 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 355 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 356 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 357 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021(USD MILLION)
    • TABLE 358 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 359 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 360 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 361 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 362 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 363 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 364 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 365 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 366 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION)
    • TABLE 367 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION)
    • TABLE 368 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION)
    • TABLE 369 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION)
    • TABLE 370 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION)
    • TABLE 371 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION)
    • TABLE 372 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION)
    • TABLE 373 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 374 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 375 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 376 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 377 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 378 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 379 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION)
    • TABLE 380 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 381 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
  • 10.3 REVENUE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2017-2022
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 34 AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022)
    • TABLE 382 AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
    • FIGURE 35 AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022)
  • 10.5 COMPANY EVALUATION MATRIX
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 36 AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
    • 10.5.5 COMPANY FOOTPRINT ANALYSIS
    • TABLE 383 OVERALL COMPANY FOOTPRINT (TEN PLAYERS)
    • TABLE 384 APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS)
    • TABLE 385 REGIONAL FOOTPRINT (TEN PLAYERS)
  • 10.6 START-UP/SME EVALUATION MATRIX
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 37 AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022)
    • 10.6.5 COMPETITIVE BENCHMARKING
    • TABLE 386 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 387 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
    • TABLE 388 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020-SEPTEMBER 2023
    • 10.7.2 DEALS
    • TABLE 389 KEY DEALS, JANUARY 2020-SEPTEMBER 2023
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 390 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020-SEPTEMBER 2023)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)**
    • 11.1.1 MICROSOFT
    • TABLE 391 MICROSOFT: COMPANY OVERVIEW
    • FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022)
    • 11.1.2 NVIDIA CORPORATION
    • TABLE 392 NVIDIA CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.3 MERATIVE
    • TABLE 393 MERATIVE: COMPANY OVERVIEW
    • FIGURE 40 IBM: COMPANY SNAPSHOT (2021)
    • 11.1.4 GOOGLE (ALPHABET, INC.)
    • TABLE 394 GOOGLE: COMPANY OVERVIEW
    • FIGURE 41 GOOGLE: COMPANY SNAPSHOT (2022)
    • 11.1.5 INTEL CORPORATION
    • TABLE 395 INTEL CORPORATION: COMPANY OVERVIEW
    • FIGURE 42 INTEL CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.6 SIEMENS HEALTHINEERS
    • TABLE 396 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
    • FIGURE 43 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
    • 11.1.7 GE HEALTHCARE
    • TABLE 397 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.8 ADVANCED MICRO DEVICES, INC.
    • TABLE 398 ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW
    • FIGURE 45 XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.9 KONINKLIJKE PHILIPS N.V.
    • TABLE 399 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.10 DIGITAL DIAGNOSTICS, INC.
    • TABLE 400 DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW
    • 11.1.11 INFORMAI
    • TABLE 401 INFORMAI: COMPANY OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 HEARTFLOW, INC.
    • 11.2.2 ENLITIC, INC.
    • 11.2.3 AIDENCE
    • 11.2.4 BUTTERFLY NETWORK, INC.
    • 11.2.5 NANO X IMAGING LTD.
    • 11.2.6 VIZ.AI, INC.
    • 11.2.7 QUIBIM
    • 11.2.8 QURE.AI
    • 11.2.9 THERAPIXEL
    • 11.2.10 AIDOC
    • 11.2.11 LUNIT, INC.
    • 11.2.12 ECHONOUS, INC.
    • 11.2.13 ICOMETRIX
    • 11.2.14 BRAINOMIX
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS